Symetis, a Boston Scientific Company, develops and produces innovative, minimally invasive heart valve replacement devices. The company’s product ACURATE neo™ and delivery systems, based on proprietary design and delivery technologies, are marketed and sold in key markets in Europe and in other markets, and are well positioned to target the constantly growing TAVI market.
There are no vacancies at the moment.
Keep an eye on this company by adding it to your Favorites.
3.8 ★4 reviews